We were able to show that (I) simultaneous combination treatment is superior to sequential therapy in 2D- and 3D-GBM models; (II) this combination upregulates cytochrome C and ATF4, leading to apoptosis; and (III) the long-term treatment has improved antineoplastic activity. The gene discussed is CYCS; the disease is glioblastoma.